IBMS 2nd Joint Meeting of the International Bone & Mineral Society
Click here to go to the previous page
Inhibiting glycogen synthase kinase-3 (GSK-3) prevents the development of myeloma bone disease
Program Code:
300-1
Date:
Wednesday, March 25, 2009
Time:
11:00 AM to 12:00 PM
EST